I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Maria Raquel Nunes, M.D.
Assistant Professor of Oncology
Languages: English, French, Portuguese, Spanish
Expertise: Breast Cancer, Cancer Genomics, Clinical Trials, Hematology and Oncology, Internal Medicine, Medical Oncology
Sibley Memorial Hospital
5255 Loughboro Road NW
Washington, DC 20016 map
Raquel Nunes, M.D., is a breast medical oncologist at the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology for the Johns Hopkins University School of Medicine. Dr. Nunes is a member of the Johns Hopkins Breast Cancer Program. She is board-certified in medical oncology, hematology and internal medicine by the American Board of Internal Medicine.
Dr. Nunes has an expertise in breast cancer, cancer genomics and clinical trials evaluating new treatment options and markers for personalized therapy. Her specific interests include predictive markers, lobular breast cancer and global health.
Dr. Nunes earned her medical degree from the University of Lisbon Medical School in Portugal. She completed a fellowship in medical oncology at the Portuguese Institute of Oncology, as well as research fellowships at the Dana-Farber Cancer Institute and the National Heart, Lung and Blood and Institute. Dr. Nunes then completed a residency at MedStar Washington Hospital Center, as well as a fellowship in hematology oncology where she served as chief fellow. Before joining Johns Hopkins, Dr. Nunes was on faculty at MedStar Washington Hospital Center, where she held an appointment as assistant professor of hematology and oncology at Georgetown University School of Medicine.
Dr. Nunes was awarded a merit award by the American Society of Clinical Oncology in 2002.
- Assistant Professor of Oncology
- MD, Universidade de Lisboa Faculdade de Medicina (1994)
- Hospital de S Jose / Internal Medicine (1996)
- Medstar Washington Hospital Center / Internal Medicine (2009)
- Portuguese Institute of Oncology / Medical Oncology (1999)
- Portuguese Institute of Oncology / Medical Oncology (2004)
- Medstar Washington Hospital Center / Hematology and Oncology (2012)
- American Board of Internal Medicine / Hematology (2012)
- American Board of Internal Medicine / Internal Medicine (2009)
- American Board of Internal Medicine / Oncology (2012)
Research & Publications
Robinson BN, Newman AF, Tefera E, Herbolsheimer P, Nunes R, Gallagher C, Randolph-Jackson P, Omogbehin A, Dilawari A, Pohlmann PR, Mohebtash M, Lee Y, Ottaviano Y, Mohapatra A, Lynce F, Brown R, Mete M, Swain SM. "Video intervention increases participation of black breast cancer patients in therapeutic trials." NPJ Breast Cancer. 2017 Sep 18;3:36. doi: 10.1038/s41523-017-0039-1. eCollection 2017.
Swain SM, Nunes R, Yoshizawa C, Rothney M, Sing AP. "Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age." Adv Ther. 2015 Dec;32(12):1222-36. doi: 10.1007/s12325-015-0268-3. Epub 2015 Nov 26.
Nunes R, Swain SM. "Pertuzumab: increasing the options." Oncology (Williston Park). 2014 Mar;28(3):199, 204, 210.
Mielke S, Nunes R, Rezvani K, Fellowes VS, Venne A, Solomon SR, Fan Y, Gostick E, Price DA, Scotto C, Read EJ, Barrett AJ. "A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique." Blood. 2008 Apr 15;111(8):4392-402. Epub 2007 Sep 18.
Mielke S, Rezvani K, Savani BN, Nunes R, Yong AS, Schindler J, Kurlander R, Ghetie V, Read EJ, Solomon SR, Vitetta ES, Barrett AJ. "Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease." Blood. 2007 Sep 1;110(5):1689-97. Epub 2007 May 3.
Videos & Media
Recent News Articles and Media Coverage
Video Intervention Increases Participation of Black Breast Cancer Patients in Therapeutic Trials, Nature, September 18, 2017
A Wonder Drug's Frightening Side Effect, U.S. News and World Report, October 20, 2015
African-American Women and Breast Cancer Risk, The International Oncology Network, June 25, 2014